Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Fluorouracil × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 39 Stomach Neoplasms 19 Pancreatic Neoplasms 16 Rectal Neoplasms 13 Esophageal Neoplasms 12 Colonic Neoplasms 11 Adenocarcinoma Of Esophagus 10 Neoplasms 9 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 9 Squamous Cell Carcinoma of Head and Neck 8 Cholangiocarcinoma 7 Biliary Tract Neoplasms 5 Urinary Bladder Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Adenocarcinoma 4 Lung Neoplasms 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Anus Neoplasms 3 Advanced Solid Tumors 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 HER2-positive Gastric Cancer 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2

Interventions

lutetium Lu 177 dotatate 3 pasireotide 2 Octreotide 2 lanreotide 1 copper dotatate CU-64 1 abemaciclib 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Lutetium-177 1 Lutetium 1 Everolimus 1 E-7386 1 Cryotherapy 1 Acupuncture Therapy 1 Acupressure 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡